The govt as well as the central drug regulatory agency have been cautious on approving any clinical trial after SC instructions

Proposals from leading pharmaceutical companies such as Novo Nordisk, Cadila Pharmaceuticals, Wockhardt, Novartis, Roche and Reliance Life Sciences for conducting clinical trials were recently rejected by a regulatory committee, formed following the Supreme Court’s directions to supervise tests of new medicines on human beings.